Anavex Life Sciences Corp (AVXL)

[Jonjones325]

Thank you for this post and the many others you have written. Your expertise is appreciated.

Although you point out some valid points, aren’t these results above and beyond the current SOC despite the deficiencies that you see?

You are looking at it like a clinician and can easily point out flaws in what a “perfect” trial success should look like.

But looking at this from the point of view in possible relief and benefits to patients in light of what is out there, should this be seen as more than a path to move onto phase 3?

Do you see any possibility of expedited paths based on what was shown? Whether it be from the tga or fda.